InNexus Biotechnology (InNexus Biotechnology) Current Accrued Expense : $0.72 Mil (As of Mar. 2011)

View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Current Accrued Expense?

InNexus Biotechnology's Current Accrued Expense for the quarter that ended in Mar. 2011 was $0.72 Mil.

InNexus Biotechnology's quarterly Current Accrued Expense increased from Sep. 2010 ($0.44 Mil) to Dec. 2010 ($0.55 Mil) and increased from Dec. 2010 ($0.55 Mil) to Mar. 2011 ($0.72 Mil).

InNexus Biotechnology's annual Current Accrued Expense declined from Jun. 2008 ($0.61 Mil) to Jun. 2009 ($0.60 Mil) and declined from Jun. 2009 ($0.60 Mil) to Jun. 2010 ($0.58 Mil).

InNexus Biotechnology Current Accrued Expense Historical Data

The historical data trend for InNexus Biotechnology's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Current Accrued Expense Chart

InNexus Biotechnology Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun06

Jun07

Jun08

Jun09

Jun10

Current Accrued Expense

Get a 7-Day Free Trial

0.09

0.61

0.60

0.58

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Current Accrued Expense	Get a 7-Day Free Trial															0.47	0.58	0.44	0.55	0.72

InNexus Biotechnology Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

InNexus Biotechnology Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology (InNexus Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7

Website

http://www.ixsbio.com

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines